EUR 86,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 75,73
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 115,35
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 115,35
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 130,77
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 115,33
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 142,05
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 208.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 142,67
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 212.
EUR 81,13
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New.
Idioma: Inglés
Publicado por Springer US, Springer New York, 2012
ISBN 10: 1461347408 ISBN 13: 9781461347408
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 112,77
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the last decade, the considerable progress made in biochemistry, molecular biology, genetics and neuropharmacology has revealed some ofthe intimate mechanisms ofthe neurodegenerative disorders. There is increasing evidence linking genetic defects affecting mitochondria to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and some other neurological disorders. Advances in knowledge are fueled through improved animal models that use mitochondrial toxins, excitotoxins, and transgenic animals. Therapeutic studies in these models have strengthened the possibility for effective treatments in man. By defining the pathomechanisms, we hope to be in the position to prevent cell death by protecting neurons. Indeed serious preclinical and clinical research is going on in the field of neuroprotection in stroke, Parkinson's disease, epilepsy, demyelinating disorders and dementia. Based on these scientific ideas, the Symposium in honour of Professor Abel Lajtha was organized by the European Society for ClinicalNeuropharmacology(ESCNP) and the Danube Symposium for Neurological Sciences in Budapest, Hungary, October 24-25, 2002. Professor Lajtha was born in Budapest in 1922 and his home town is an ideal venue for strengthening the bonds between Western and Eastern European Neuroscientists. Professor Peter Riederer (Wurzburg) held the 2002 special 'Dezso Miskolczy Memorial Lecture' in Abel Lajtha's Honour. Thanks are due to the invited speakersofthis Symposium for their excellentcontribution. Laszlo Vecsei vii CONTENTS Advances in Neuroprotection Research for Neurodegenerative Diseases 1 Mario E. Gotz and Peter Riederer Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction 21 Laszlo G. Harsing, Jr.
Idioma: Inglés
Publicado por Springer US, Springer New York, 2003
ISBN 10: 0306480387 ISBN 13: 9780306480386
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 114,36
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the last decade, the considerable progress made in biochemistry, molecular biology, genetics and neuropharmacology has revealed some ofthe intimate mechanisms ofthe neurodegenerative disorders. There is increasing evidence linking genetic defects affecting mitochondria to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and some other neurological disorders. Advances in knowledge are fueled through improved animal models that use mitochondrial toxins, excitotoxins, and transgenic animals. Therapeutic studies in these models have strengthened the possibility for effective treatments in man. By defining the pathomechanisms, we hope to be in the position to prevent cell death by protecting neurons. Indeed serious preclinical and clinical research is going on in the field of neuroprotection in stroke, Parkinson's disease, epilepsy, demyelinating disorders and dementia. Based on these scientific ideas, the Symposium in honour of Professor Abel Lajtha was organized by the European Society for ClinicalNeuropharmacology(ESCNP) and the Danube Symposium for Neurological Sciences in Budapest, Hungary, October 24-25, 2002. Professor Lajtha was born in Budapest in 1922 and his home town is an ideal venue for strengthening the bonds between Western and Eastern European Neuroscientists. Professor Peter Riederer (Wurzburg) held the 2002 special 'Dezso Miskolczy Memorial Lecture' in Abel Lajtha's Honour. Thanks are due to the invited speakersofthis Symposium for their excellentcontribution. Laszlo Vecsei vii CONTENTS Advances in Neuroprotection Research for Neurodegenerative Diseases 1 Mario E. Gotz and Peter Riederer Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction 21 Laszlo G. Harsing, Jr.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 172,62
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 163,11
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. Like New. book.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 195,86
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 184,54
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 78,67
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 73,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHRD. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 103,10
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 110,18
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 102,49
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 106,99
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the last decade, the considerable progress made in biochemistry, molecular biology, genetics and neuropharmacology has revealed some ofthe intimate mechanisms ofthe neurodegenerative disorders. There is increasing evidence linking genetic defects affecting mitochondria to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and some other neurological disorders. Advances in knowledge are fueled through improved animal models that use mitochondrial toxins, excitotoxins, and transgenic animals. Therapeutic studies in these models have strengthened the possibility for effective treatments in man. By defining the pathomechanisms, we hope to be in the position to prevent cell death by protecting neurons. Indeed serious preclinical and clinical research is going on in the field of neuroprotection in stroke, Parkinson's disease, epilepsy, demyelinating disorders and dementia. Based on these scientific ideas, the Symposium in honour of Professor Abel Lajtha was organized by the European Society for ClinicalNeuropharmacology(ESCNP) and the Danube Symposium for Neurological Sciences in Budapest, Hungary, October 24-25, 2002. Professor Lajtha was born in Budapest in 1922 and his home town is an ideal venue for strengthening the bonds between Western and Eastern European Neuroscientists. Professor Peter Riederer (Wurzburg) held the 2002 special 'Dezso Miskolczy Memorial Lecture' in Abel Lajtha's Honour. Thanks are due to the invited speakersofthis Symposium for their excellentcontribution. Laszlo Vecsei vii CONTENTS Advances in Neuroprotection Research for Neurodegenerative Diseases 1 Mario E. Gotz and Peter Riederer Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction 21 Laszlo G. Harsing, Jr. 208 pp. Englisch.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 106,99
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the last decade, the considerable progress made in biochemistry, molecular biology, genetics and neuropharmacology has revealed some ofthe intimate mechanisms ofthe neurodegenerative disorders. There is increasing evidence linking genetic defects affecting mitochondria to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and some other neurological disorders. Advances in knowledge are fueled through improved animal models that use mitochondrial toxins, excitotoxins, and transgenic animals. Therapeutic studies in these models have strengthened the possibility for effective treatments in man. By defining the pathomechanisms, we hope to be in the position to prevent cell death by protecting neurons. Indeed serious preclinical and clinical research is going on in the field of neuroprotection in stroke, Parkinson's disease, epilepsy, demyelinating disorders and dementia. Based on these scientific ideas, the Symposium in honour of Professor Abel Lajtha was organized by the European Society for ClinicalNeuropharmacology(ESCNP) and the Danube Symposium for Neurological Sciences in Budapest, Hungary, October 24-25, 2002. Professor Lajtha was born in Budapest in 1922 and his home town is an ideal venue for strengthening the bonds between Western and Eastern European Neuroscientists. Professor Peter Riederer (Wurzburg) held the 2002 special 'Dezso Miskolczy Memorial Lecture' in Abel Lajtha's Honour. Thanks are due to the invited speakersofthis Symposium for their excellentcontribution. Laszlo Vecsei vii CONTENTS Advances in Neuroprotection Research for Neurodegenerative Diseases 1 Mario E. Gotz and Peter Riederer Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction 21 Laszlo G. Harsing, Jr. 210 pp. Englisch.
Librería: moluna, Greven, Alemania
EUR 92,27
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Advances in Neuroprotection Research for Neurodegenerative Diseases.- Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction.- Neuroprotection in Ischemic/Hypoxic Disorders: From the Preclinical to the Clinical Testin.
Librería: moluna, Greven, Alemania
EUR 92,27
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Advances in Neuroprotection Research for Neurodegenerative Diseases.- Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction.- Neuroprotection in Ischemic/Hypoxic Disorders: From the Preclinical to the Clinical Testin.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 147,30
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 208 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 147,43
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 212 Illus.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 148,51
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 212.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 148,57
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 208.
Librería: preigu, Osnabrück, Alemania
EUR 95,70
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Frontiers in Clinical Neuroscience | Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha's Honour | Laszlo Vecsei | Buch | ix | Englisch | 2003 | Springer US | EAN 9780306480386 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.